Literature DB >> 8259878

Nitric oxide treatment for fulminant pulmonary hypertension.

K G Allman1, J D Young, J E Stevens, L N Archer.   

Abstract

A 3 year old child with known pulmonary haemosiderosis suffered acute circulatory collapse secondary to raised pulmonary vascular resistance. Nitric oxide inhalation produced a profound improvement in circulatory parameters and gaseous exchange. Nitric oxide may have a therapeutic role in acute pulmonary hypertensive crisis.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8259878      PMCID： PMC1029555          DOI： 10.1136/adc.69.4.449

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects.

Authors:  A Haydar; T Malhere; P Mauriat; D Journois; P Pouard; N Denis; D Lefèbvre; D Safran; P Vouhé
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J D Roberts; D M Polaner; P Lang; W M Zapol
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

4.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245
  4 in total
  1 in total

1.  Effects of oxygen and nitric oxide in oxygen on pulmonary arterial pressures of children with congenital cardiac defects.

Authors:  K G Allman; J D Young; D Carapiet; J E Stevens; I Ostman-Smith; L N Archer
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.